You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A blogger ponders the mechanics of open science.
One scientist wants to create a virtual C. elegans and another wants to create a virtual scientist.
A blogger uses humor to dive into the ethics of spinning research results.
Nature has parthenogenetic stem cells, a fly RNAi library, and more this week.
More turtles, please, says Malaysia.
Saliva-based technologies abound.
Where are you on the biotech food chain?
China put the former head of its food and drug administration to death after he admitted taking bribes.
Cloning will be just one tool open to farmers, says a news report.
A blogger asks readers to give the NIH their input about its grant-giving system.
Studying a prospective source of biofuel gets the money rolling in.
Paradigm shift in cancer theory? A blogger thinks not.
This month's Nature Biotechnology has a primer on shotgun proteomic algorithms and a series of articles on engineering nucleases for gene therapy.
A comparison of Caenorhabditis genomes underscores the importance of chromosomal architecture.
Does a family own its genetic information?
The New York Times looks into synthetic biology.
A review of Michael Sandel's new book "The Case Against Perfection."
The 'octosquid,' possibly a new species, has surfaced in Hawaii.
No Chatty Cathies, Sea Anemones Sequenced, Greenland's DNA, and more in this issue of Science.
As all eyes turn to synthetic biology, the possibilities seem tremendous -- but the regulatory landscape remains uncharted.
A group of Israeli scientists report building a computer made entirely of DNA.
To add to the arena of evolutionary biologists weighing in on religion, we've got David Sloan Wilson taking issue with Richard Dawkins.
Nature gets into GINA, science fiction, mirtrons and more in this week's issue.
A review from Richard Dawkins pans the latest book from intelligent design advocate Michael Behe.
In the latest New York Review of Books, Freeman Dyson addresses what he sees as "our biotech future" -- a rosy place where biotech is as omnipresent and helpful as computers.
Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.
The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.